Anteris Technologies’ DurAVR valve sustains strong one-year performance in small annuli patients

About this content About Lisa Uhlman Lisa Uhlman is an equities reporter at Proactive Investors, covering ASX-listed companies across the mining, energy, biotech and emerging tech sectors. With a background in legal and financial journalism, Lisa brings a sharp analytical lens to market news and corporate developments. Prior to joining Proactive, she reported for national trade publications and newswires, with a focus on court reporting, regulatory affairs and ESG-related business issues. Based in Sydney ...